Zum Hauptinhalt springen

oncostatin M receptor

Der OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

Videoauswahl für Gene
Videothek

Normal function

Der OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

OSM receptor type II interacts with a protein called oncostatin M (OSM). Signaling triggered by OSM was first recognized to block the growth of cancerous cells and appears to play a role in many other body processes, including the development of blood cells, the maturation of cells to become certain cell types, and an immune system response called inflammation. The signaling may also block the self-destruction (apoptosis) of cells.

The IL-31 receptor interacts with a protein called IL-31. Signaling triggered by IL-31 is involved in inflammation and stimulating itching (pruritus), although its role is not completely understood.

Conditions referring to this gene or chromosome

Other names

IL-31 receptor subunit beta

IL-31R subunit beta

IL-31R-beta

IL-31RB

interleukin-31 receptor subunit beta

oncostatin-M specific receptor beta subunit

OSMRB

PLCA1

Related patient information and medicines

IgA-Nephropathie

Patient information leaflet

IgA-Nephropathie

IgA-Nephropathie is a condition in which a protein causes damage to the kidneys. The medicines used for blood pressure control with IgA nephropathy are angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors or angiotensin receptor blockers (ARBs) - for example, losartan Losartan - an angiotensin receptor blocker. Even if you don't have high.

Koronararterien-Bypass-Operation

Patient information leaflet

Koronararterien-Bypass-Operation

C oronary artery bypass grafting (CABG) is a type of heart surgery to treat coronary artery disease. The standard surgery requires open heart surgery and stopping of the heart temporarily. Coronary artery bypass grafting, called CABG for short (pronounced 'cabbage'), is a heart operation. It is also called coronary artery bypass surgery. A CABG is.

Dilatative Kardiomyopathie

Patient information leaflet

Dilatative Kardiomyopathie

Dilatative Kardiomyopathie is a condition where the heart muscle becomes stretched and thin. The heart becomes enlarged (dilates) and pumps blood less well. Symptoms vary according to severity and the treatment depends on the type of symptoms and whether any complications develop. Some forms of dilated cardiomyopathy run in families. A normal heart.

Familiäre Hypercholesterinämie

Patient information leaflet

Familiäre Hypercholesterinämie

Familiäre Hypercholesterinämie is inherited high cholesterol. The usual medicine to start with is a statin Statins und andere lipid-lowering medicines. ...mmon Statin used is called atorvastatinDr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Diabetes und Krankheit

Patient information leaflet

Diabetes und Krankheit

It is very important to know how to cope with illness if you have Diabetes or know or care for somebody with diabetes. Further information on managing diabetes während a period of illness ist available on the Diabetes UK website (see Further Reading below for the link). On angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors , angiotensin.

Myasthenia gravis

Patient information leaflet

Myasthenia gravis

Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune.

Artikelverlauf

Die Informationen auf dieser Seite werden von qualifizierten Klinikern verfasst und begutachtet.
  • 18. Aug 2020 | Neueste Version
  • 1 Oct 2016 | Ursprünglich veröffentlicht

Nehmen Sie an der Diskussion teil

Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.

Haftungsausschluss: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online-Apotheke, Behandlungen und Gesundheitsdienstleistungen

Einfacher Zugang zu vertrauenswürdigen Behandlungen und Gesundheitsdiensten online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Abonnieren Sie den Patienten-Newsletter

Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.

Bitte geben Sie eine gültige E-Mail-Adresse ein

Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.